A Comparison of Long-Term Outcomes in Patients Managed With Venovenous Extracorporeal Membrane Oxygenation in the First and Second Waves of the COVID-19 Pandemic in the United Kingdom

Crit Care MedPublished Retrospective cohort study

Main finding · Survival at censoring date and decannulationResult — go to the resultχ 2 6.35

Authors' conclusion

Most patients with COVID-19 supported on ECMO in both waves survived in the short and longer term. At follow-up patients had similar lung function and QOL across the two waves.

Study context

Population
Patients supported on venovenous extracorporeal membrane oxygenation (ECMO) for COVID-19 in a severe acute respiratory failure service, UKincluded in analysis
Participants
123 patients
Exposure
COVID-19 wave 2 vs wave 1 patients supported on venovenous ECMO
Outcome
Survival at censoring date and decannulation
Methodological detailssingle-center
  • Single-center

Main finding

As reported in the abstract

χ 2

6.35

P = 0.012

Survival at decannulation significantly lower in wave 2 (90.4% vs 70.0%)
P < 0.001

Observational data: associations, not effects.

Further findings

Duration of ECMO run · longer in wave 2

P = 0.005

Factors independently associated with increased mortality

OR (CI)P value
Age1.07 (1.01–1.14)P = 0.025
NIV use3.37 (1.12–12.60)P = 0.043

Noninvasive ventilation (NIV) before ECMO

Longer NIV application prior to ECMO in wave 2

QOL and lung function · first follow-up

Similar across waves, apart from transfer coefficient of carbon monoxide corrected for hemoglobin

Safety

Higher frequency of barotrauma in wave 2

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

A Comparison of Long-Term Outcomes in Patients Managed With Venovenous Extracorporeal Membrane Oxygenation in the First and Second Waves of the COVID-19 Pandemic in the United Kingdom. Crit Care Med. Published 5 April 2023. doi:10.1097/ccm.0000000000005864

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.